Garrett Winslow serves as Executive at F-star Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Garrett Winslow has executed 10 insider transactions totaling $21.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved exercising options for 680 shares valued at $0.
Garrett Winslow currently holds 1,320 shares of F-star Therapeutics, Inc. (SBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Garrett Winslow has been a net buyer of SBPH stock. They have purchased $14.6K and sold $7.2K worth of shares.
Garrett Winslow's most recent insider trade was on Jan 2, 2026, when they sold 680 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $21.38 |
| Discretionary |
| Jan 2, 2026 | GLTO | $0 | Option Exercise | 680 | $N/A | Discretionary |
| Jul 3, 2025 | GLTO | $881 | Sale | 260 | $3.39 | Discretionary |
| Jul 3, 2025 | GLTO | $0 | Option Exercise | 680 | $N/A | Discretionary |
| Dec 3, 2021 | GLTO | $5.0K | Purchase | 2,000 | $2.48 | Discretionary |
| Jun 23, 2021 | GLTO | $9.6K | Purchase | 2,000 | $4.80 | Discretionary |
| Nov 20, 2020 | SBPH | $833 | Sale | 175 | $4.76 | Discretionary |
| Nov 19, 2020 | SBPH | $0 | Award | 12,500 | $N/A | Discretionary |
| Nov 19, 2020 | SBPH | $0 | Option Exercise | 6,250 | $N/A | Discretionary |